{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:49:13Z","timestamp":1792633753541,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008233","name":"Shanghai Jiao Tong University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.yexcr.2020.111857","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T11:58:14Z","timestamp":1579521494000},"page":"111857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["PP121 suppresses RANKL-Induced osteoclast formation in vitro and LPS-Induced bone resorption in vivo"],"prefix":"10.1016","volume":"388","author":[{"given":"Zhihang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichuan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.yexcr.2020.111857_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1759720X16670154","article-title":"Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis","volume":"8","author":"Langdahl","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"9773","key":"10.1016\/j.yexcr.2020.111857_bib2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.yexcr.2020.111857_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.joca.2015.10.008","article-title":"Osteoclasts are recruited to the subchondral bone in naturally occurring post-traumatic equine carpal osteoarthritis and may contribute to cartilage degradation","volume":"24","author":"Bertuglia","year":"2016","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.yexcr.2020.111857_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcp.2016.04.010","article-title":"Pharmacological inhibition of cathepsin K: a promising novel approach for postmenopausal osteoporosis therapy","volume":"117","author":"Mukherjee","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.yexcr.2020.111857_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/jfb8040042","article-title":"The effect of RANKL\/OPG balance on reducing implant complications","volume":"8","author":"Kapasa","year":"2017","journal-title":"J. Funct. Biomater."},{"issue":"6","key":"10.1016\/j.yexcr.2020.111857_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158365","article-title":"Barriers to effective postmenopausal osteoporosis treatment: a qualitative study of patients' and practitioners' views","volume":"11","author":"Alami","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2020.111857_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","article-title":"Prevention and treatment of postmenopausal osteoporosis","volume":"142","author":"Tella","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"7","key":"10.1016\/j.yexcr.2020.111857_bib8","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/jbmr.5650100706","article-title":"Characterization of MCSF-induced proliferation and subsequent osteoclast formation in murine marrow culture","volume":"10","author":"Biskobing","year":"1995","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.yexcr.2020.111857_bib9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(99)00210-0","article-title":"Osteoblasts\/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor\/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand","volume":"25","author":"Udagawa","year":"1999","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.yexcr.2020.111857_bib10","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/sj.cdd.4401882","article-title":"Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL","volume":"13","author":"Huang","year":"2006","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.yexcr.2020.111857_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/cr.2010.159","article-title":"Role of NF-kappaB in the skeleton","volume":"21","author":"Novack","year":"2011","journal-title":"Cell Res."},{"issue":"17","key":"10.1016\/j.yexcr.2020.111857_bib12","doi-asserted-by":"crossref","first-page":"E3481","DOI":"10.1073\/pnas.1702367114","article-title":"Roles of the TRAF6 and pellino E3 ligases in MyD88 and RANKL signaling","volume":"114","author":"Strickson","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.yexcr.2020.111857_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7150\/ijbs.13814","article-title":"Selective regulation of MAPK signaling mediates RANKL-dependent osteoclast differentiation","volume":"12","author":"Lee","year":"2016","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.yexcr.2020.111857_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020601","article-title":"Inhibitory effect of purpurogallin on osteoclast differentiation in vitro through the downregulation of c-fos and NFATc1","volume":"19","author":"Kim","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.yexcr.2020.111857_bib15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1083\/jcb.119.4.1003","article-title":"Osteoclasts express high levels of pp60c-src in association with intracellular membranes","volume":"119","author":"Horne","year":"1992","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.yexcr.2020.111857_bib16","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1172\/JCI116032","article-title":"Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice","volume":"90","author":"Boyce","year":"1992","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.yexcr.2020.111857_bib17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","article-title":"Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice","volume":"64","author":"Soriano","year":"1991","journal-title":"Cell"},{"issue":"5827","key":"10.1016\/j.yexcr.2020.111857_bib18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.yexcr.2020.111857_bib19","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.1158\/0008-5472.CAN-04-4392","article-title":"Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.yexcr.2020.111857_bib20","doi-asserted-by":"crossref","first-page":"8659","DOI":"10.1007\/s13277-014-2118-3","article-title":"PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, inhibits anaplastic thyroid carcinoma cell proliferation and migration","volume":"35","author":"Che","year":"2014","journal-title":"Tumor Biol."},{"issue":"11","key":"10.1016\/j.yexcr.2020.111857_bib21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nchembio.117","article-title":"Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases","volume":"4","author":"Apsel","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.yexcr.2020.111857_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbrc.2015.07.147","article-title":"The anti-esophageal cancer cell activity by a novel tyrosine\/phosphoinositide kinase inhibitor PP121","volume":"465","author":"Peng","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.yexcr.2020.111857_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bcp.2014.10.019","article-title":"Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro","volume":"93","author":"Wu","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"24","key":"10.1016\/j.yexcr.2020.111857_bib24","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1016\/j.biomaterials.2014.04.044","article-title":"The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-kappaB and NFATc1 signaling","volume":"35","author":"Zhai","year":"2014","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.yexcr.2020.111857_bib25","doi-asserted-by":"crossref","first-page":"16665","DOI":"10.1038\/s41598-017-16853-w","article-title":"Kaempferide prevents titanium particle induced osteolysis by suppressing JNK activation during osteoclast formation","volume":"7","author":"Jiao","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.yexcr.2020.111857_bib26","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jcp.25907","article-title":"Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo","volume":"233","author":"Wei","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.yexcr.2020.111857_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40273-014-0231-1","article-title":"A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis","volume":"33","author":"Hiligsmann","year":"2015","journal-title":"PharmacoEconomics"},{"issue":"10","key":"10.1016\/j.yexcr.2020.111857_bib28","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s00198-015-3164-4","article-title":"Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study","volume":"26","author":"Hadji","year":"2015","journal-title":"Osteoporos. Int."},{"issue":"12","key":"10.1016\/j.yexcr.2020.111857_bib29","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1185\/030079907X242890","article-title":"The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates","volume":"23","author":"McHorney","year":"2007","journal-title":"Curr. Med. Res. Opin."},{"issue":"4","key":"10.1016\/j.yexcr.2020.111857_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7196\/SAMJ.7505","article-title":"The safety of osteoporosis medication","volume":"104","author":"Hough","year":"2014","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.yexcr.2020.111857_bib31","doi-asserted-by":"crossref","first-page":"13700","DOI":"10.1038\/ncomms13700","article-title":"Galpha13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3beta-NFATc1 signalling pathway","volume":"8","author":"Wu","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.yexcr.2020.111857_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7150\/ijbs.13814","article-title":"Selective regulation of MAPK signaling mediates RANKL-dependent osteoclast differentiation","volume":"12","author":"Lee","year":"2016","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.yexcr.2020.111857_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI200419657","article-title":"Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation","volume":"114","author":"Ikeda","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2020.111857_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2016.02.057","article-title":"Herbacetin inhibits RANKL-mediated osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo","volume":"777","author":"Li","year":"2016","journal-title":"Eur. J. Pharmacol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482720300513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482720300513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:27:08Z","timestamp":1757996828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482720300513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0014482720300513"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2020.111857","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PP121 suppresses RANKL-Induced osteoclast formation in vitro and LPS-Induced bone resorption in vivo","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2020.111857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111857"}}